IRIS UniCatt

Caldarola, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.068
EU - Europa 2.929
AS - Asia 1.447
SA - Sud America 333
AF - Africa 55
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.850
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.025
DE - Germania 1.023
SG - Singapore 621
CN - Cina 489
SE - Svezia 466
BR - Brasile 308
IT - Italia 299
FR - Francia 242
UA - Ucraina 241
IE - Irlanda 157
FI - Finlandia 132
GB - Regno Unito 117
ID - Indonesia 109
RU - Federazione Russa 73
IN - India 61
PL - Polonia 50
KR - Corea 39
BE - Belgio 26
CA - Canada 24
TR - Turchia 24
EG - Egitto 22
AT - Austria 21
CI - Costa d'Avorio 20
HK - Hong Kong 20
NL - Olanda 18
JP - Giappone 16
CZ - Repubblica Ceca 12
AR - Argentina 10
ES - Italia 9
MX - Messico 8
NZ - Nuova Zelanda 8
IR - Iran 7
MY - Malesia 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
IQ - Iraq 6
MA - Marocco 6
RO - Romania 6
VN - Vietnam 6
BD - Bangladesh 5
BO - Bolivia 4
EC - Ecuador 4
EU - Europa 4
LT - Lituania 4
NO - Norvegia 4
PA - Panama 4
ZA - Sudafrica 4
CY - Cipro 3
DK - Danimarca 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
GT - Guatemala 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PR - Porto Rico 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.850
Salva come PNG Salva come JPEG
Città #
Chandler 682
Singapore 364
Ashburn 236
Dublin 153
Jacksonville 141
San Mateo 132
Jakarta 109
New York 95
Nanjing 92
Wilmington 81
Ann Arbor 79
Helsinki 68
Woodbridge 67
Boston 63
Dearborn 61
Milan 60
Rome 58
The Dalles 58
Bremen 57
Munich 55
Houston 51
Nürnberg 48
Cattolica 47
Los Angeles 46
Princeton 46
Hefei 45
North Bergen 44
Boardman 41
Kraków 41
Lawrence 41
Moscow 41
Beijing 40
Frankfurt am Main 38
Seoul 36
Nanchang 32
Redwood City 31
Seattle 31
Marseille 27
São Paulo 27
Fairfield 26
Paris 25
Brussels 23
Düsseldorf 23
Abidjan 20
Leawood 19
Hong Kong 18
Kunming 18
Hebei 17
London 17
Nuremberg 16
Redmond 16
Detroit 15
Chicago 14
Norwalk 14
Vienna 14
Hyderabad 13
Shenyang 13
Shanghai 12
Curitiba 11
Izmir 11
Rio de Janeiro 11
Tianjin 11
Brasília 10
Brooklyn 10
Changsha 10
Falkenstein 10
Jiaxing 10
Lauterbourg 10
Mountain View 10
University Park 10
Zhengzhou 10
Brno 9
Guangzhou 9
Portsmouth 9
Roubaix 9
Augusta 8
Newark 8
Ottawa 8
Toronto 8
Cairo 7
Fremont 7
Hangzhou 7
Lancaster 7
Washington 7
Amsterdam 6
Esslingen am Neckar 6
Stockholm 6
Turku 6
Ypsilanti 6
Ankara 5
As Santah 5
Auckland 5
Boydton 5
Charlotte 5
Feasterville Trevose 5
Lappeenranta 5
Pune 5
Simi Valley 5
Southampton 5
Sydney 5
Totale 4.119
Salva come PNG Salva come JPEG
Nome #
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 172
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 164
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 151
Linear atrophoderma of Moulin 129
Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis 129
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 123
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 121
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 119
Exacerbation of pemphigus after influenza vaccination. 115
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? 114
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 113
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. 112
Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment 111
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients 110
Circumscribed pityriasis rubra pilaris type IV 109
Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study 109
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 106
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 105
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study 105
Management of recurrent cutaneous abscesses during therapy with infliximab 103
Clinical and ultrasonographic profile of adalimumab-treated hidradenitis suppurativa patients: A real-life monocentric experience 103
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 101
Evaluation of Endothelial Dysfunction in Psoriatic Patients by Different Techniques 97
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study 97
TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients 96
IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses 94
Lichenoid reaction induced by adalimumab 90
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports 90
Dyshidrosiform pemphigoid: a well-defined clinical entity? 89
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 89
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 89
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 86
Etanercept therapy for psoriasis in a patient with numerous comorbidities 85
Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy 84
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 83
Psychopathology and eating disorders in patients with psoriasis 82
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 81
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 79
Human leukocyte antigen-B*58:01 allele in a familial case of Stevens-Johnson syndrome induced by allopurinol 79
Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. 77
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 77
Lichen sclerosus of the glans simulating melanoma 77
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 76
development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine 75
Dermoscopy of cutaneous sarcoidosis. 74
Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations 73
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic 73
Role of personalized medication training in improving efficacy and adherence to a topical therapy 73
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature 72
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 71
Dermoscopy of melanocytic lesions in patients affected by oculocutaneous albinism: a case series 68
Childhood trauma and resilience in psoriatic patients: A preliminary report 68
Biological agents targeting interleukin-13 for atopic dermatitis 67
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 66
Clinico-dermoscopic features of alopecia areata in patients with psoriasis 63
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination 63
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis 62
Untreated Psoriasis Impairs Male Fertility: A Case-Control Study 61
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 61
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 60
Ixekizumab exposure associated with myelitis: A case report and a literature review 59
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy 58
Dermoscopy of necrobiosis lipoidica and granuloma annulare 57
A case of chronic disseminated lupus erythematosus in a psoriatic patient receiving ustekinumab 57
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 56
Childhood trauma and resilience in psoriatic patients: A preliminary report. 56
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 56
Granuloma faciale: a case report on long-term treatment with topical tacrolimus and dermoscopic aspects 55
Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy 53
The preclinical discovery and development of deucravacitinib for the treatment of psoriasis 51
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 51
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life. 51
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study 50
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis 50
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study 49
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study 48
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study 47
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 47
Multiple eruptive plaque-like dermatofibromas during anti-TNFα treatment 46
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) 45
IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses 44
Recalcitrant Sweet Syndrome successfully treated with adalimumab 44
Severe and resistant palmar psoriasis successfully treated with risankizumab 43
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study 42
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 41
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 41
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 41
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a “real-world”, mono-center experience 40
A case of guttate psoriasis during treatment with dupilumab 39
2-Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy 37
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients 35
Multiple paradoxical reactions during ixekizumab therapy 34
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 32
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 31
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 31
A case of eczematous eruption occurring during treatment with risankizumab 30
Living with chronic spontaneous urticaria in Italy: A narrative medicine project to improve the pathway of patient care 30
Annular elastolytic giant cell granuloma following herpes zoster infection 29
Drug survival of methotrexate and predictor factors for discontinuation in psoriasis 28
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 26
Totale 7.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 0 0 0 0 0 0 79 71
2020/2021511 14 62 13 53 69 24 51 40 62 16 99 8
2021/2022665 75 54 20 19 33 20 10 113 16 40 129 136
2022/20231.782 218 255 117 280 145 221 64 139 237 22 60 24
2023/2024980 41 235 41 135 29 122 55 45 16 36 121 104
2024/20252.078 59 60 178 67 182 168 71 117 391 212 573 0
Totale 7.967